Stocks
ProKidney Corp.PROK
NASDAQHealthcareBiotechnology$1.93
A clinical-stage biotechnology company developing autologous cell therapies aimed at slowing or preventing progression of chronic kidney disease. Its lead program focuses on regenerative treatments designed to preserve kidney function and reduce the need for dialysis or transplantation. Investors tr...
52W Range: $0.46 – $7.13
Congressional Interest in ProKidney Corp. (PROK)
No congressional trades have been disclosed for ProKidney Corp. (PROK) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading PROK?
No congressional trades found for this stock.